EUVIMEDEUVIMED entdecken
Crossref

Preoperative Thrombocytosis Is an Independent Poor Prognostic Factor in Patients with Epithelial Ovarian Cancer

Jisu Oh, Min Chul Choi, Hyun Park, Chan Lee, Jun Mo Lee, So Young Chong, Doyeun Oh

Clinical & Experimental Thrombosis and Hemostasis · 2014

DOI: 10.14345/ceth.14006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Thrombosis and Hemostasis, 2014. Verfasst von Jisu Oh und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Platelets may promote cancer progression through diverse mechanisms, including protection of cancer cells from immune surveillance, cancer-cell arrest in the microvasculature, and stimulation of angiogenesis. We investigated whether platelet count was related to clinical outcome in epithelial ovarian cancer (EOC).

Methods

Clinical data from 377 patients with EOC diagnosed at CHA Bundang Medical Center from January 2000 to June 2013 were retrospectively analyzed. Thrombocytosis was defined as a platelet count of more than 450,000/mm2.

Results

Stage III/IV ovarian cancer was correlated with higher median platelet counts than stage I/II disease (281,000/mm3 vs. 263,000/mm3, P= 0.002). Twenty-eight (7.5%) out of 377 patients had thrombocytosis at the time of initial diagnosis of EOC. Patients with thrombocytosis were significantly more likely to have advanced stage disease (OR= 3.288, P= 0.008) and higher preoperative levels of median cancer antigen (CA) 125 than those with normal platelet counts (221.7 vs. 28.2 ng/mL, P< 0.001). Patients with thrombocytosis had a significantly shorter median time to progression-free survival (PFS) and overall survival (OS) than those with normal platelet counts, respectively (median PFS 20.9 vs. 78.4 months, P= 0.002 and median OS 64 months vs. not reached, P= 0.001). In the multivariate analysis, the presence of thrombocytosis, advanced stage, and suboptimal cytoreduction were significantly associated with decreased OS.

Conclusion

Preoperative thrombocytosis is closely linked to poor clinical outcome in patients with EOC. Keywords: Thrombocytosis, Clinical outcomes, Epithelial ovarian cancer

Zitieren

APA

Oh, J., Choi, M. C., Park, H., Lee, C., Lee, J. M., Chong, S. Y., & Oh, D. (2014). Preoperative Thrombocytosis Is an Independent Poor Prognostic Factor in Patients with Epithelial Ovarian Cancer. Clinical & Experimental Thrombosis and Hemostasis. https://doi.org/10.14345/ceth.14006

Vancouver

Oh J, Choi MC, Park H, Lee C, Lee JM, Chong SY, et al. Preoperative Thrombocytosis Is an Independent Poor Prognostic Factor in Patients with Epithelial Ovarian Cancer. Clinical & Experimental Thrombosis and Hemostasis. 2014. doi:10.14345/ceth.14006

BibTeX
@article{Oh2014,
  author = {Oh, Jisu and Choi, Min Chul and Park, Hyun and Lee, Chan and Lee, Jun Mo and Chong, So Young and Oh, Doyeun},
  title = {Preoperative Thrombocytosis Is an Independent Poor Prognostic Factor in Patients with Epithelial Ovarian Cancer},
  journal = {Clinical & Experimental Thrombosis and Hemostasis},
  year = {2014},
  doi = {10.14345/ceth.14006}
}
Kostenlos starten →